Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

The impact of thoracic paravertebral block over post-operatory evolution in open lobectomy.

Popovici BI, Matei D, Iacoban L, Simion I, Man M, Al Hajjar N, Mois E, Popovici C, Chira R, Iancu C.

Ann Ital Chir. 2019 Sep 9;8. pii: S0003469X19030641. [Epub ahead of print]

PMID:
31525164
2.

Heart Rate Variability and Vagus Nerve Stimulation in Epilepsy Patients.

Constantinescu V, Matei D, Constantinescu I, Cuciureanu DI.

Transl Neurosci. 2019 Aug 24;10:223-232. doi: 10.1515/tnsci-2019-0036. eCollection 2019.

3.

Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience.

Sparchez Z, Mocan T, Hajjar NA, Bartos A, Hagiu C, Matei D, Craciun R, Mocan LP, Sparchez M, Leucuta DC.

Med Ultrason. 2019 Aug 31;21(3):217-224. doi: 10.11152/mu-1957.

4.

NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.

Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Berek JS, Chen LM, Cristea M, DeRosa M, ElNaggar AC, Gershenson DM, Gray HJ, Hakam A, Jain A, Johnston C, Leath CA III, Liu J, Mahdi H, Matei D, McHale M, McLean K, O'Malley DM, Penson RT, Percac-Lima S, Ratner E, Remmenga SW, Sabbatini P, Werner TL, Zsiros E, Burns JL, Engh AM.

J Natl Compr Canc Netw. 2019 Aug 1;17(8):896-909. doi: 10.6004/jnccn.2019.0039.

PMID:
31390583
5.

A case of giant cell tumor of the tendon sheath in an elderly patient: diagnostic difficulties and therapeutic options.

Matei D, Marcu IR, Pătru GL, Pătru L, Bighea AC, Pătru S.

Rom J Morphol Embryol. 2019;60(1):293-296.

6.

Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up.

Luzzago S, Catellani M, Di Trapani E, Cozzi G, Mistretta FA, Bianchi R, Pricolo P, Conti A, Ancona E, Piacentini N, Alessi S, Renne G, Ferro M, Matei DV, Musi G, Alicja Jereczek-Fossa B, Petralia G, de Cobelli O.

Prostate Cancer Prostatic Dis. 2019 Jun 27. doi: 10.1038/s41391-019-0160-3. [Epub ahead of print]

PMID:
31249386
7.

CD73: an emerging checkpoint for cancer immunotherapy.

Chen S, Wainwright DA, Wu JD, Wan Y, Matei DE, Zhang Y, Zhang B.

Immunotherapy. 2019 Aug;11(11):983-997. doi: 10.2217/imt-2018-0200. Epub 2019 Jun 21.

PMID:
31223045
8.

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer.

Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, Moxley KM, Kim YM, Powell MA, O'Malley DM, Spirtos NM, Small W Jr, Tewari KS, Richards WE, Nakayama J, Matulonis UA, Huang HQ, Miller DS.

N Engl J Med. 2019 Jun 13;380(24):2317-2326. doi: 10.1056/NEJMoa1813181.

PMID:
31189035
9.

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer.

Cantiello F, Russo GI, Vartolomei MD, Farhan ARA, Terracciano D, Musi G, Lucarelli G, Di Stasi SM, Hurle R, Serretta V, Busetto GM, Scafuro C, Perdonà S, Borghesi M, Schiavina R, Cioffi A, De Berardinis E, Almeida GL, Bove P, Lima E, Ucciero G, Matei DV, Crisan N, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Mirone V, Shariat SF, Ferro M.

Eur Urol Oncol. 2018 Oct;1(5):403-410. doi: 10.1016/j.euo.2018.06.006. Epub 2018 Jul 13.

PMID:
31158079
10.

Small Molecules Target the Interaction between Tissue Transglutaminase and Fibronectin.

Sima LE, Yakubov B, Zhang S, Condello S, Grigorescu AA, Nwani NG, Chen L, Schiltz GE, Arvanitis C, Zhang ZY, Matei D.

Mol Cancer Ther. 2019 Jun;18(6):1057-1068. doi: 10.1158/1535-7163.MCT-18-1148. Epub 2019 Apr 23.

PMID:
31015308
11.

A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer.

Nwani NG, Condello S, Wang Y, Swetzig WM, Barber E, Hurley T, Matei D.

Cancers (Basel). 2019 Apr 8;11(4). pii: E502. doi: 10.3390/cancers11040502.

12.

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Moore KN, Secord AA, Geller MA, Miller DS, Cloven N, Fleming GF, Wahner Hendrickson AE, Azodi M, DiSilvestro P, Oza AM, Cristea M, Berek JS, Chan JK, Rimel BJ, Matei DE, Li Y, Sun K, Luptakova K, Matulonis UA, Monk BJ.

Lancet Oncol. 2019 May;20(5):636-648. doi: 10.1016/S1470-2045(19)30029-4. Epub 2019 Apr 1. Erratum in: Lancet Oncol. 2019 May;20(5):e242.

PMID:
30948273
13.

Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer.

Goodman CR, Hatoum S, Seagle BL, Donnelly ED, Barber EL, Shahabi S, Matei DE, Strauss JB.

Gynecol Oncol. 2019 Apr;153(1):41-48. doi: 10.1016/j.ygyno.2019.01.007. Epub 2019 Jan 16.

PMID:
30660345
14.

Epithelial Mutations in Endometriosis: Link to Ovarian Cancer.

Bulun SE, Wan Y, Matei D.

Endocrinology. 2019 Mar 1;160(3):626-638. doi: 10.1210/en.2018-00794.

PMID:
30657901
15.

The Influence of Physical Exercise on Smoking Patients with Peripheral Arterial Disease.

Patru S, Marcu IR, Matei D, Bighea AC.

Curr Health Sci J. 2018 Jan-Mar;44(1):34-38. doi: 10.12865/CHSJ.44.01.06. Epub 2018 Mar 23.

16.

Targeting Cancer Stemness in the Clinic: From Hype to Hope.

Saygin C, Matei D, Majeti R, Reizes O, Lathia JD.

Cell Stem Cell. 2019 Jan 3;24(1):25-40. doi: 10.1016/j.stem.2018.11.017. Epub 2018 Dec 27. Review.

PMID:
30595497
17.

Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer.

Cowan M, Strauss JB, Barber EL, Matei D.

Curr Opin Obstet Gynecol. 2019 Feb;31(1):31-37. doi: 10.1097/GCO.0000000000000506.

PMID:
30571659
18.

Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies: Time to Improve Radiologists' Training Program?

Luzzago S, Petralia G, Musi G, Catellani M, Alessi S, Di Trapani E, Mistretta FA, Serino A, Conti A, Pricolo P, Nazzani S, Mirone V, Matei DV, Montanari E, de Cobelli O.

Clin Genitourin Cancer. 2019 Apr;17(2):88-96. doi: 10.1016/j.clgc.2018.10.006. Epub 2018 Oct 23.

PMID:
30527286
19.

Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028.

Varga A, Piha-Paul S, Ott PA, Mehnert JM, Berton-Rigaud D, Morosky A, Yang P, Ruman J, Matei D.

Gynecol Oncol. 2019 Feb;152(2):243-250. doi: 10.1016/j.ygyno.2018.11.017. Epub 2018 Dec 3.

PMID:
30522700
20.

Predictors of Residual T1 High Grade on Re-Transurethral Resection in a Large Multi-Institutional Cohort of Patients with Primary T1 High-Grade/Grade 3 Bladder Cancer.

Ferro M, Di Lorenzo G, Buonerba C, Lucarelli G, Russo GI, Cantiello F, Farhan ARA, Di Stasi S, Musi G, Hurle R, Vincenzo S, Busetto GM, De Berardinis E, Perdonà S, Borghesi M, Schiavina R, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Mistretta FA, Crisan N, Terracciano D, Paolo V, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, Muto M, Rocca R, Mirone V, de Cobelli O, Vartolomei MD.

J Cancer. 2018 Oct 20;9(22):4250-4254. doi: 10.7150/jca.26129. eCollection 2018.

21.

IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.

Wang Y, Zong X, Mitra S, Mitra AK, Matei D, Nephew KP.

JCI Insight. 2018 Dec 6;3(23). pii: 122360. doi: 10.1172/jci.insight.122360.

22.

Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.

Ferro M, Musi G, Serino A, Cozzi G, Mistretta FA, Costa B, Bianchi R, Cordima G, Luzzago S, Di Trapani E, Tagliabue E, Vartolomei MD, Terracciano D, Cassatella MC, Salvatici M, Conti A, Sandri MT, Cioffi A, Turetti M, Catellani M, Bottero D, Matei DV, Mirone V, de Cobelli O.

Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8.

PMID:
30408799
23.

siRNA Delivery Using Dithiocarbamate-Anchored Oligonucleotides on Gold Nanorods.

Wang J, Thomas M, Lin P, Cheng JX, Matei DE, Wei A.

Bioconjug Chem. 2019 Feb 20;30(2):443-453. doi: 10.1021/acs.bioconjchem.8b00723. Epub 2018 Nov 15.

PMID:
30395447
24.

Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.

Friedlander M, Matulonis U, Gourley C, du Bois A, Vergote I, Rustin G, Scott C, Meier W, Shapira-Frommer R, Safra T, Matei D, Shirinkin V, Selle F, Fielding A, Lowe ES, McMurtry EL, Spencer S, Rowe P, Mann H, Parry D, Ledermann J.

Br J Cancer. 2018 Oct;119(9):1075-1085. doi: 10.1038/s41416-018-0271-y. Epub 2018 Oct 24.

PMID:
30353045
25.

Long-term oncologic and functional outcomes after robot-assisted partial nephrectomy in elderly patients.

Vartolomei MD, Matei DV, Renne G, Tringali VM, Crișan N, Musi G, Mistretta FA, Russo A, Conti A, Cozzi G, Luzzago S, Catellani M, Cioffi A, Cordima G, Bianchi R, Di Trapani E, Serino A, Delor M, Bianco R, Bottero D, Ferro M, De Cobelli O.

Minerva Urol Nefrol. 2019 Feb;71(1):31-37. doi: 10.23736/S0393-2249.18.03006-0. Epub 2018 Sep 19.

PMID:
30230293
26.

Targeting the Microenvironment in High Grade Serous Ovarian Cancer.

Nwani NG, Sima LE, Nieves-Neira W, Matei D.

Cancers (Basel). 2018 Aug 10;10(8). pii: E266. doi: 10.3390/cancers10080266. Review.

27.

An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.

Ferro M, Vartolomei MD, Russo GI, Cantiello F, Farhan ARA, Terracciano D, Cimmino A, Di Stasi S, Musi G, Hurle R, Serretta V, Busetto GM, De Berardinis E, Cioffi A, Perdonà S, Borghesi M, Schiavina R, Cozzi G, Almeida GL, Bove P, Lima E, Grimaldi G, Matei DV, Crisan N, Muto M, Verze P, Battaglia M, Guazzoni G, Autorino R, Morgia G, Damiano R, de Cobelli O, Shariat S, Mirone V, Lucarelli G.

World J Urol. 2019 Mar;37(3):507-514. doi: 10.1007/s00345-018-2397-1. Epub 2018 Jul 10.

PMID:
29992381
28.

Dual Combined Laparoscopic Approach for Renal-Cell Carcinoma with Renal Vein and Level I-II Inferior Vena Cava Thrombus: Our Technique and Initial Results.

Crisan N, Andras I, Grad DL, Telecan T, Coman RT, de Cobelli O, Matei DV, Coman I.

J Endourol. 2018 Sep 12;32(9):837-842. doi: 10.1089/end.2018.0228. Epub 2018 Aug 3.

PMID:
29947249
29.

Hormonal strategies in gynecologic cancer: Bridging biology and therapy.

Nieves-Neira W, Kim JJ, Matei D.

Gynecol Oncol. 2018 Aug;150(2):207-210. doi: 10.1016/j.ygyno.2018.06.005. Epub 2018 Jun 20. No abstract available.

PMID:
29933928
30.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
31.

Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer.

Cozzi G, Musi G, Bianchi R, Bottero D, Brescia A, Cioffi A, Cordima G, Delor M, Di Trapani E, Ferro M, Matei DV, Russo A, Mistretta FA, De Cobelli O.

Ther Adv Urol. 2017 Oct 9;9(11):241-250. doi: 10.1177/1756287217731449. eCollection 2017 Nov.

32.

An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.

Pulliam N, Fang F, Ozes AR, Tang J, Adewuyi A, Keer H, Lyons J, Baylin SB, Matei D, Nakshatri H, Rassool FV, Miller KD, Nephew KP.

Clin Cancer Res. 2018 Jul 1;24(13):3163-3175. doi: 10.1158/1078-0432.CCR-18-0204. Epub 2018 Apr 3.

33.

Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity.

Özeş AR, Pulliam N, Ertosun MG, Yılmaz Ö, Tang J, Çopuroğlu E, Matei D, Özeş ON, Nephew KP.

Oncogene. 2018 Jun;37(26):3589-3600. doi: 10.1038/s41388-018-0218-z. Epub 2018 Mar 26.

34.

Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche.

Condello S, Sima L, Ivan C, Cardenas H, Schiltz G, Mishra RK, Matei D.

Cancer Res. 2018 Jun 1;78(11):2990-3001. doi: 10.1158/0008-5472.CAN-17-2319. Epub 2018 Mar 6.

35.

A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses.

Matei D, Ghamande S, Roman L, Alvarez Secord A, Nemunaitis J, Markham MJ, Nephew KP, Jueliger S, Oganesian A, Naim S, Su XY, Keer H, Azab M, Fleming GF.

Clin Cancer Res. 2018 May 15;24(10):2285-2293. doi: 10.1158/1078-0432.CCR-17-3055. Epub 2018 Mar 2.

36.

CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.

Oleinika K, Rosser EC, Matei DE, Nistala K, Bosma A, Drozdov I, Mauri C.

Nat Commun. 2018 Feb 15;9(1):684. doi: 10.1038/s41467-018-02911-y.

37.

Outcomes of robotic-assisted radical prostatectomy for patients in two extreme age-groups (< 50 years vs > 65 years).

Coman RT, Crisan N, Andras I, Bud G, Matei DV, DE Cobelli O, Coman I, Bocsan IS.

Clujul Med. 2018;91(1):92-97. doi: 10.15386/cjmed-825. Epub 2018 Jan 15.

38.

Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes.

Musi G, Mistretta FA, Marenghi C, Russo A, Catellani M, Nazzani S, Conti A, Luzzago S, Ferro M, Matei DV, Carmignani L, de Cobelli O.

J Endourol. 2018 Mar;32(3):257-263. doi: 10.1089/end.2017.0915. Epub 2018 Feb 21.

PMID:
29357686
39.

Ultrastable Silicon Cavity in a Continuously Operating Closed-Cycle Cryostat at 4 K.

Zhang W, Robinson JM, Sonderhouse L, Oelker E, Benko C, Hall JL, Legero T, Matei DG, Riehle F, Sterr U, Ye J.

Phys Rev Lett. 2017 Dec 15;119(24):243601. doi: 10.1103/PhysRevLett.119.243601. Epub 2017 Dec 15.

PMID:
29286721
40.

Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

Fang F, Cardenas H, Huang H, Jiang G, Perkins SM, Zhang C, Keer HN, Liu Y, Nephew KP, Matei D.

Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11.

41.

Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Musi G, Russo A, Conti A, Mistretta FA, Di Trapani E, Luzzago S, Bianchi R, Renne G, Ramoni S, Ferro M, Matei DV, Cusini M, Carmignani L, de Cobelli O.

World J Urol. 2018 Feb;36(2):265-270. doi: 10.1007/s00345-017-2144-z. Epub 2017 Dec 2.

PMID:
29197968
42.

Robot-assisted Partial Nephrectomy: 5-yr Oncological Outcomes at a Single European Tertiary Cancer Center.

Vartolomei MD, Matei DV, Renne G, Tringali VM, Crisan N, Musi G, Mistretta FA, Russo A, Cozzi G, Cordima G, Luzzago S, Cioffi A, Di Trapani E, Catellani M, Delor M, Bottero D, Imbimbo C, Mirone V, Ferro M, de Cobelli O.

Eur Urol Focus. 2019 Jul;5(4):636-641. doi: 10.1016/j.euf.2017.10.005. Epub 2017 Oct 27.

PMID:
29111154
43.

Linear and nonlinear parameters of heart rate variability in ischemic stroke patients.

Constantinescu V, Matei D, Costache V, Cuciureanu D, Arsenescu-Georgescu C.

Neurol Neurochir Pol. 2018 Mar;52(2):194-206. doi: 10.1016/j.pjnns.2017.10.002. Epub 2017 Oct 11.

PMID:
29110883
44.

Effects of biofeedback versus switch-triggered functional electrical stimulation on sciatica-related foot drop.

Sardaru DP, Matei D, Zaharia-Kezdi D, Pendefunda L.

J Back Musculoskelet Rehabil. 2018;31(2):239-245. doi: 10.3233/BMR-169578.

PMID:
28946515
45.

Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis.

Bocsan IC, Milaciu MV, Pop RM, Vesa SC, Ciumarnean L, Matei DM, Buzoianu AD.

Oxid Med Cell Longev. 2017;2017:4297206. doi: 10.1155/2017/4297206. Epub 2017 Aug 9.

46.

Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.

Andras I, Crisan N, Vesa S, Rahota R, Romanciuc F, Lazar A, Socaciu C, Matei DV, de Cobelli O, Bocsan IS, Coman RT.

Future Oncol. 2017 Aug;13(20):1793-1800. doi: 10.2217/fon-2017-0078. Epub 2017 Aug 4.

PMID:
28776421
47.

Robot-Assisted Vesico-Vaginal Fistula Repair: Our Technique and Review of the Literature.

Matei DV, Zanagnolo V, Vartolomei MD, Crisan N, Ferro M, Bocciolone L, Maggioni A, Coman I, de Cobelli O.

Urol Int. 2017;99(2):137-142. doi: 10.1159/000475887. Epub 2017 Jul 26. Review.

PMID:
28743109
48.

1.5  μm Lasers with Sub-10 mHz Linewidth.

Matei DG, Legero T, Häfner S, Grebing C, Weyrich R, Zhang W, Sonderhouse L, Robinson JM, Ye J, Riehle F, Sterr U.

Phys Rev Lett. 2017 Jun 30;118(26):263202. doi: 10.1103/PhysRevLett.118.263202. Epub 2017 Jun 28.

PMID:
28707932
49.

Outcomes of robot-assisted simple enucleation of renal masses: A single European center experience.

Matei DV, Vartolomei MD, Musi G, Renne G, Tringali VML, Mistretta FA, Delor M, Russo A, Cioffi A, Bianchi R, Cozzi G, Di Trapani E, Bottero D, Cordima G, Lucarelli G, Ferro M, de Cobelli O.

Medicine (Baltimore). 2017 May;96(18):e6771. doi: 10.1097/MD.0000000000006771.

50.

The hunt for elusive cancer stem cells.

Condello S, Nwani NG, Matei D.

Oncotarget. 2017 Jun 13;8(24):38076-38077. doi: 10.18632/oncotarget.17443. No abstract available.

Supplemental Content

Support Center